LifeSpan Vision Ventures

LifeSpan Vision Ventures is a venture capital firm focused on early-stage investments in companies developing therapeutics for longevity and the reversal of aging-related diseases. Their mission is to enable healthy, strong, and vibrant human lifespans beyond 120 years, with a primary focus on the whole body, joints, heart, skin, brain, and muscles.

The firm offers deep scientific and technological expertise, leading or participating in founding, seed, angel, early, and mid-stage investment rounds. They leverage strong financial market contacts to secure necessary working capital through various financing methods and have a proven track record in founding and leading startups that demonstrate rapid and successful growth. Their extensive network with academics, professionals, and institutions facilitates collaboration and synergy, accelerating development timelines and uncovering new possibilities.

LifeSpan Vision Ventures has invested in several companies, including Matter Bio, a longevity holding company focused on preserving genome integrity, and Rejuvenation Technologies, an early-stage biotech company developing mRNA therapies to address aging and age-related diseases. These investments underscore the firm's commitment to advancing innovative therapies that extend healthspan and improve the quality of life as individuals age.